Monotherapy Epilepsy: Topirama ( topiramate) Tablets are indicated as initial monotherapy in patients 6 years of age and older with partial onset or primary generalized tonic-clonic seizures.
Adjunctive Therapy Epilepsy: Topirama ( topiramate) Tablets are indicated as adjunctive therapy for adults and pediatric patients ages 2 – 16 years with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with Lennox-Gastaut syndrome.
Migraine: Topirama ( topiramate) Tablets are indicated in adults for the prophylaxis of migraine headache. The usefulness of topiramate in the acute treatment of migraine has not been studied.
Explore more products from our portfolio
